We are in exciting times with psychedelic medicines.  In the last decade, research has resumed with FDA  approved  studies involving MDMA and psilocybin (mushrooms).  With Phase 3 studies beginning now, the potential for prescription of MDMA and psilocybin in the early 2020s looms large. And available now is the potent dissociative anesthetic ketamine which has […]